STAT3 and lung carcinoma: In addition, western blotting analysis of lysate from lung cancer cells treated with STX-0119 showed that STX-0119 decreased the expression of STAT3 target proteins such as c-Myc, cyclin D1, and survivin in a concentration-dependent manner (Fig. 1c).